Report
Michael B. Schäfer

Wacker Chemie AG : Q1 EBITDA 2% ahead of consensus, outlook unchanged and in line with consensus

>Q1 EBITDA of € 281m flat q-o-q adj. for 1-off gain in Q4, 2% ahead of consensus (+9% vs ODDO) - EBITDA of € 281m was at upper end of the projected range of € 250-280m vs € 285m in Q4 2022 adjusted for € 70m one-off gain. This is 2% ahead of the consensus of € 277m (ODDO € 257m). Sales declined 16% y-o-y to € 1,744m (consensus € 1,744m) with volumes at -14.3% vs -7.3% y-o-y in Q4 and tough comparisons.Chemicals EBITDA up 70% q-o-q excl. one-off gain in Q4...
Underlying
Wacker Chemie AG

Wacker Chemie is active in chemical products. Co. operates in five divisions: Wacker Silicones, which provides products ranging from silicone fluids and emulsions, resins, elastomers and sealants, to silanes and pyrogenic silica grades; Wacker Polymers, which manufactures binders and polymeric additives (such as dispersible polymer powders and dispersions); Wacker Biosolutions, which supplies customized biotech and catalog products for the fine-chemical sector; Wacker Polysilicon, which produces hyperpure polysilicon for the semiconductor, electronics and above all, solar sectors; and Siltronic, which supplies semiconductor manufacturers with silicon wafers.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

ResearchPool Subscriptions

Get the most out of your insights

Get in touch